These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 25753634)
21. Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease. Min J; Park J; Lee YJ; Kim SJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH Int J Tuberc Lung Dis; 2015 Oct; 19(10):1239-45. PubMed ID: 26459540 [TBL] [Abstract][Full Text] [Related]
23. Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Kitada S; Uenami T; Yoshimura K; Tateishi Y; Miki K; Miki M; Hashimoto H; Fujikawa T; Mori M; Matsuura K; Kuroyama M; Maekura R Int J Tuberc Lung Dis; 2012 May; 16(5):660-4. PubMed ID: 22410245 [TBL] [Abstract][Full Text] [Related]
24. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease. Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077 [TBL] [Abstract][Full Text] [Related]
25. Redevelopment after spontaneous sputum conversion in noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease. Kim OH; Chong YP; Shim TS; Jo KW J Infect Chemother; 2021 Aug; 27(8):1156-1161. PubMed ID: 33745810 [TBL] [Abstract][Full Text] [Related]
27. Comparison of treatment outcomes between intermittent and daily regimens in non-cavitary nodular bronchiectatic-type Jung J; Chong YP; Lee HJ; Shim TS; Jo K-W Antimicrob Agents Chemother; 2023 Nov; 67(11):e0100323. PubMed ID: 37843254 [TBL] [Abstract][Full Text] [Related]
28. Clinical Outcome with Standard Regimen plus Clofazimine or Moxifloxacin in Cavitary Mycobacterium avium Complex Pulmonary Disease. Park YE; Chong YP; Lee HJ; Shim TS; Jo KW Antimicrob Agents Chemother; 2022 Dec; 66(12):e0052822. PubMed ID: 36326247 [TBL] [Abstract][Full Text] [Related]
29. Comparison of Clinical Features, Virulence, and Relapse among Mycobacterium avium Complex Species. Boyle DP; Zembower TR; Reddy S; Qi C Am J Respir Crit Care Med; 2015 Jun; 191(11):1310-7. PubMed ID: 25835090 [TBL] [Abstract][Full Text] [Related]
30. Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start? Nguyen MH; Daley CL Clin Chest Med; 2023 Dec; 44(4):771-783. PubMed ID: 37890915 [TBL] [Abstract][Full Text] [Related]
31. Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease. Choi H; Kim SY; Lee H; Jhun BW; Park HY; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872066 [TBL] [Abstract][Full Text] [Related]
32. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Ye JJ; Wu TS; Chiang PC; Lee MH J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469 [TBL] [Abstract][Full Text] [Related]
33. Outcomes of Koh WJ; Moon SM; Kim SY; Woo MA; Kim S; Jhun BW; Park HY; Jeon K; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Kim H; Kwon OJ Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28954780 [TBL] [Abstract][Full Text] [Related]
34. Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Han DW; Jo KW; Kim OH; Shim TS Respir Med; 2021 Apr; 179():106340. PubMed ID: 33618079 [TBL] [Abstract][Full Text] [Related]
35. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. Lee G; Lee KS; Moon JW; Koh WJ; Jeong BH; Jeong YJ; Kim HJ; Woo S Ann Am Thorac Soc; 2013 Aug; 10(4):299-306. PubMed ID: 23952847 [TBL] [Abstract][Full Text] [Related]
36. Treatment Outcomes of Mycobacterium avium Complex Lung Disease: A Systematic Review and Meta-analysis. Kwak N; Park J; Kim E; Lee CH; Han SK; Yim JJ Clin Infect Dis; 2017 Oct; 65(7):1077-1084. PubMed ID: 28582488 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282 [TBL] [Abstract][Full Text] [Related]
38. Treatment for Mycobacterium avium complex lung disease. Pan SW; Shu CC; Feng JY; Su WJ J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S67-S75. PubMed ID: 32446754 [TBL] [Abstract][Full Text] [Related]
39. Relapse versus Reinfection of Mycobacterium avium Complex Pulmonary Disease. Patient Characteristics and Macrolide Susceptibility. Boyle DP; Zembower TR; Qi C Ann Am Thorac Soc; 2016 Nov; 13(11):1956-1961. PubMed ID: 27599038 [TBL] [Abstract][Full Text] [Related]